HDFC Life Gets IRDAI Approval to Reappoint Vibha Padalkar as MD & CEO, Niraj Shah as CFO for 5 More Years
HDFC Life: IRDAI has approved the continuation of HDFC Life’s top leadership for another five-year term. The reappointments cover MD & CEO Vibha Padalkar and CFO Niraj Shah.

HDFC Life has secured IRDAI approval to reappoint Vibha Padalkar as MD & CEO and Niraj Shah as CFO for another five years.
HDFC Life: The Insurance Regulatory and Development Authority of India (IRDAI) has approved the re-appointment of Vibha Padalkar as Managing Director & Chief Executive Officer for a further five-year term, effective September 12, 2026, HDFC Life said in an exchange filing on Wednesday.
The regulator also cleared the re-appointment of Niraj Shah as Executive Director & Chief Financial Officer for another five-year term, effective April 26, 2026.
Both appointments had earlier been recommended by the company’s Nomination & Remuneration Committee, approved by the Board of Directors, and cleared by shareholders at the Annual General Meeting held on July 16, 2026, with the requisite majority. IRDAI’s sign-off was the last regulatory approval needed for the re-appointments to take effect.
Also Read: Best Pet Insurance Companies in India: 5 Things to Compare Before You Buy
Padalkar’s Nearly Two Decades at HDFC Life
Padalkar joined HDFC Life in 2008 and spent a decade as Executive Director & Chief Financial Officer before being elevated to MD & CEO in September 2018. During her time as CFO, she was closely involved in the company’s stock market listing in 2017. Her upcoming term, beginning September 2026, will be her third as CEO, taking her tenure in the corner office past eight years and her overall association with the company to nearly two decades.
Niraj Shah, who took over as CFO in 2019, oversees finance, product development and process excellence at the insurer.
HDFC Life: Premium Growth Has Stayed Strong Through FY27
HDFC Life’s topline has continued to expand through Padalkar’s tenure. For the quarter ended June 30, 2026 (Q1 FY27), the company reported net premium income of Rs 16,728 crore, up 15.1% year-on-year, while total premium rose to Rs 17,166 crore. Renewal premium grew 19% year-on-year, and net profit for the quarter rose 11-12% to Rs 611 crore from Rs 546 crore a year earlier.
Annualised Premium Equivalent (APE), a standard industry metric for new business, rose 9% to Rs 3,515 crore in the June quarter, while the Value of New Business (VNB) came in at Rs 879 crore with a margin of 25%. Assets Under Management, including that of subsidiary HDFC Pension Fund Management, crossed Rs 5.7 lakh crore during the quarter, and the company’s solvency ratio stood at 185%, above the regulatory minimum of 150%.
For the full year FY25, HDFC Life had reported 16% growth in total APE to Rs 15,479 crore and 13% growth in new business premium to Rs 33,365 crore.
Also Read: Tamil Nadu Health Insurance: Govt To Launch Plans For Elderly. All You Need To Know
HDFC Life: Share Price Has Slipped Despite Business Growth
Despite steady growth in premiums and profit, HDFC Life’s stock has underperformed over the past year. As of August 18, 2026, shares of the company were trading around Rs 543, down close to 32% over the preceding twelve months. The stock has also declined nearly 29% since the start of calendar year 2026 and is trading well below its 52-week high of Rs 815, though marginally above its 52-week low of Rs 530.50.
The company’s market capitalisation stood at roughly Rs 1.2 lakh crore as of early August 2026.
Analysts have largely attributed the disconnect between operating performance and stock price to broader pressure on insurance valuations, a moderation in growth expectations for FY27, and a dip in the solvency ratio from 192% a year earlier, even as it remained comfortably above the regulatory floor. The company raised Rs 1,000 crore through a preferential share allotment to HDFC Bank in July 2026, along with additional subordinated debt, to shore up its capital buffer ahead of an expected transition to a risk-based capital regime.
HDFC Life Insurance Company Limited is a joint venture between HDFC Bank and Abrdn plc (formerly Standard Life Aberdeen), and is listed on both the National Stock Exchange (NSE: HDFCLIFE) and BSE (Security Code: 540777).
